PubMed:8632999
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-101 | Sentence | denotes | CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. |
| T2 | 102-241 | Sentence | denotes | Tumor necrosis factor (TNF) mediates a wide variety of disease states including septic shock, acute and chronic inflammation, and cachexia. |
| T3 | 242-510 | Sentence | denotes | Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin lethality [Bianchi, M., Ulrich, P., Bloom, O., Meistrell, M., Zimmerman, G. |
| T4 | 511-601 | Sentence | denotes | A., Schmidtmayerova, H., Bukrinsky, M., Donnelley, T., Bucala, R., Sherry, B., Manogue, K. |
| T5 | 602-619 | Sentence | denotes | R., Tortolani, A. |
| T6 | 620-647 | Sentence | denotes | J., Cerami, A. & Tracey, K. |
| T7 | 648-662 | Sentence | denotes | J. (1995) Mol. |
| T8 | 663-667 | Sentence | denotes | Med. |
| T9 | 668-728 | Sentence | denotes | 1, 254-266, and Bianchi, M., Bloom, O., Raabe, T., Cohen, P. |
| T10 | 729-850 | Sentence | denotes | S., Chesney, J., Sherry, B., Schmidtmayerova, H., Zhang, X., Bukrinsky, M., Ulrich, P., Cerami, A. & Tracey, J. (1996) J. |
| T11 | 851-855 | Sentence | denotes | Exp. |
| T12 | 856-872 | Sentence | denotes | Med., in press]. |
| T13 | 873-1039 | Sentence | denotes | We have now elucidated the mechanism by which CNI-1493 inhibits macrophage TNF synthesis and show here that it acts through suppression of TNF translation efficiency. |
| T14 | 1040-1372 | Sentence | denotes | CNI-1493 blocked neither the lipopolysaccharide (LPS)-induced increases in the expression of TNF mRNA nor the translocation of nuclear factor NF-kappa B to the nucleus in macrophages activated by 15 min of LPS stimulation, indicating that CNI-1493 does not interfere with early NF-kappa B-mediated transcriptional regulation of TNF. |
| T15 | 1373-1463 | Sentence | denotes | However, synthesis of the 26-kDa membrane form of TNF was effectively blocked by CNI-1493. |
| T16 | 1464-1690 | Sentence | denotes | Further evidence for the translational suppression of TNF is given by experiments using chloram-phenicol acetyltransferase (CAT) constructs containing elements of the TNF gene that are involved in TNF translational regulation. |
| T17 | 1691-1817 | Sentence | denotes | Both the 5' and 3' untranslated regions of the TNF gene were required to elicit maximal translational suppression by CNI-1493. |
| T18 | 1818-2004 | Sentence | denotes | Identification of the molecular target through which CNI-1493 inhibits TNF translation should provide insight into the regulation of macrophage activation and mechanisms of inflammation. |
| T1 | 0-101 | Sentence | denotes | CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. |
| T2 | 102-241 | Sentence | denotes | Tumor necrosis factor (TNF) mediates a wide variety of disease states including septic shock, acute and chronic inflammation, and cachexia. |
| T3 | 242-510 | Sentence | denotes | Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin lethality [Bianchi, M., Ulrich, P., Bloom, O., Meistrell, M., Zimmerman, G. |
| T4 | 511-601 | Sentence | denotes | A., Schmidtmayerova, H., Bukrinsky, M., Donnelley, T., Bucala, R., Sherry, B., Manogue, K. |
| T5 | 602-619 | Sentence | denotes | R., Tortolani, A. |
| T6 | 620-647 | Sentence | denotes | J., Cerami, A. & Tracey, K. |
| T7 | 648-662 | Sentence | denotes | J. (1995) Mol. |
| T8 | 663-667 | Sentence | denotes | Med. |
| T9 | 668-728 | Sentence | denotes | 1, 254-266, and Bianchi, M., Bloom, O., Raabe, T., Cohen, P. |
| T10 | 729-850 | Sentence | denotes | S., Chesney, J., Sherry, B., Schmidtmayerova, H., Zhang, X., Bukrinsky, M., Ulrich, P., Cerami, A. & Tracey, J. (1996) J. |
| T11 | 851-855 | Sentence | denotes | Exp. |
| T12 | 856-872 | Sentence | denotes | Med., in press]. |
| T13 | 873-1039 | Sentence | denotes | We have now elucidated the mechanism by which CNI-1493 inhibits macrophage TNF synthesis and show here that it acts through suppression of TNF translation efficiency. |
| T14 | 1040-1372 | Sentence | denotes | CNI-1493 blocked neither the lipopolysaccharide (LPS)-induced increases in the expression of TNF mRNA nor the translocation of nuclear factor NF-kappa B to the nucleus in macrophages activated by 15 min of LPS stimulation, indicating that CNI-1493 does not interfere with early NF-kappa B-mediated transcriptional regulation of TNF. |
| T15 | 1373-1463 | Sentence | denotes | However, synthesis of the 26-kDa membrane form of TNF was effectively blocked by CNI-1493. |
| T16 | 1464-1690 | Sentence | denotes | Further evidence for the translational suppression of TNF is given by experiments using chloram-phenicol acetyltransferase (CAT) constructs containing elements of the TNF gene that are involved in TNF translational regulation. |
| T17 | 1691-1817 | Sentence | denotes | Both the 5' and 3' untranslated regions of the TNF gene were required to elicit maximal translational suppression by CNI-1493. |
| T18 | 1818-2004 | Sentence | denotes | Identification of the molecular target through which CNI-1493 inhibits TNF translation should provide insight into the regulation of macrophage activation and mechanisms of inflammation. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-59 | protein | denotes | monocyte/macrophage tumor necrosis factor |
| T2 | 102-123 | protein | denotes | Tumor necrosis factor |
| T3 | 125-128 | protein | denotes | TNF |
| T4 | 366-369 | protein | denotes | TNF |
| T5 | 948-951 | protein | denotes | TNF |
| T6 | 1012-1015 | protein | denotes | TNF |
| T7 | 1133-1141 | RNA | denotes | TNF mRNA |
| T8 | 1167-1192 | protein | denotes | nuclear factor NF-kappa B |
| T9 | 1211-1222 | cell_type | denotes | macrophages |
| T10 | 1318-1328 | protein | denotes | NF-kappa B |
| T11 | 1368-1371 | protein | denotes | TNF |
| T12 | 1399-1419 | protein | denotes | 26-kDa membrane form |
| T13 | 1423-1426 | protein | denotes | TNF |
| T14 | 1518-1521 | protein | denotes | TNF |
| T15 | 1552-1603 | DNA | denotes | chloram-phenicol acetyltransferase (CAT) constructs |
| T16 | 1631-1639 | DNA | denotes | TNF gene |
| T17 | 1661-1664 | protein | denotes | TNF |
| T18 | 1700-1730 | DNA | denotes | 5' and 3' untranslated regions |
| T19 | 1738-1746 | DNA | denotes | TNF gene |
| T20 | 1889-1892 | protein | denotes | TNF |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-101 | Sentence | denotes | CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. |
| S2 | 102-241 | Sentence | denotes | Tumor necrosis factor (TNF) mediates a wide variety of disease states including septic shock, acute and chronic inflammation, and cachexia. |
| S3 | 242-872 | Sentence | denotes | Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin lethality [Bianchi, M., Ulrich, P., Bloom, O., Meistrell, M., Zimmerman, G. A., Schmidtmayerova, H., Bukrinsky, M., Donnelley, T., Bucala, R., Sherry, B., Manogue, K. R., Tortolani, A. J., Cerami, A. & Tracey, K. J. (1995) Mol. Med. 1, 254-266, and Bianchi, M., Bloom, O., Raabe, T., Cohen, P. S., Chesney, J., Sherry, B., Schmidtmayerova, H., Zhang, X., Bukrinsky, M., Ulrich, P., Cerami, A. & Tracey, J. (1996) J. Exp. Med., in press]. |
| S4 | 873-1039 | Sentence | denotes | We have now elucidated the mechanism by which CNI-1493 inhibits macrophage TNF synthesis and show here that it acts through suppression of TNF translation efficiency. |
| S5 | 1040-1372 | Sentence | denotes | CNI-1493 blocked neither the lipopolysaccharide (LPS)-induced increases in the expression of TNF mRNA nor the translocation of nuclear factor NF-kappa B to the nucleus in macrophages activated by 15 min of LPS stimulation, indicating that CNI-1493 does not interfere with early NF-kappa B-mediated transcriptional regulation of TNF. |
| S6 | 1373-1463 | Sentence | denotes | However, synthesis of the 26-kDa membrane form of TNF was effectively blocked by CNI-1493. |
| S7 | 1464-1690 | Sentence | denotes | Further evidence for the translational suppression of TNF is given by experiments using chloram-phenicol acetyltransferase (CAT) constructs containing elements of the TNF gene that are involved in TNF translational regulation. |
| S8 | 1691-1817 | Sentence | denotes | Both the 5' and 3' untranslated regions of the TNF gene were required to elicit maximal translational suppression by CNI-1493. |
| S9 | 1818-2004 | Sentence | denotes | Identification of the molecular target through which CNI-1493 inhibits TNF translation should provide insight into the regulation of macrophage activation and mechanisms of inflammation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-8 | NP | denotes | CNI-1493 |
| C2 | 102-129 | NP | denotes | Tumor necrosis factor (TNF) |
| C3 | 252-292 | NP | denotes | a multivalent guanylhydrazone (CNI-1493) |
| C5 | 896-909 | NP | denotes | the mechanism |
| C6 | 913-918 | NP | denotes | which |
| C7 | 919-927 | NP | denotes | CNI-1493 |
| C4 | 896-961 | NP | denotes | the mechanism by which CNI-1493 inhibits macrophage TNF synthesis |
| C8 | 981-983 | NP | denotes | it |
| C9 | 1040-1048 | NP | denotes | CNI-1493 |
| C10 | 1279-1287 | NP | denotes | CNI-1493 |
| C11 | 1368-1371 | NP | denotes | TNF |
| C12 | 1423-1426 | NP | denotes | TNF |
| C13 | 1454-1462 | NP | denotes | CNI-1493 |
| C14 | 1518-1521 | NP | denotes | TNF |
| C15 | 1627-1639 | NP | denotes | the TNF gene |
| C16 | 1640-1644 | NP | denotes | that |
| C17 | 1734-1746 | NP | denotes | the TNF gene |
| C18 | 1808-1816 | NP | denotes | CNI-1493 |
| C19 | 1836-1856 | NP | denotes | the molecular target |
| C20 | 1865-1870 | NP | denotes | which |
| C21 | 1871-1879 | NP | denotes | CNI-1493 |
| R1 | C3 | C1 | coref-ident | a multivalent guanylhydrazone (CNI-1493),CNI-1493 |
| R2 | C6 | C4 | coref-relat | which,the mechanism by which CNI-1493 inhibits macrophage TNF synthesis |
| R3 | C7 | C3 | coref-ident | CNI-1493,a multivalent guanylhydrazone (CNI-1493) |
| R4 | C8 | C5 | coref-pron | it,the mechanism |
| R5 | C9 | C7 | coref-ident | CNI-1493,CNI-1493 |
| R6 | C10 | C9 | coref-ident | CNI-1493,CNI-1493 |
| R7 | C11 | C2 | coref-ident | TNF,Tumor necrosis factor (TNF) |
| R8 | C12 | C11 | coref-ident | TNF,TNF |
| R9 | C13 | C10 | coref-ident | CNI-1493,CNI-1493 |
| R10 | C14 | C12 | coref-ident | TNF,TNF |
| R11 | C16 | C15 | coref-relat | that,the TNF gene |
| R12 | C17 | C15 | coref-ident | the TNF gene,the TNF gene |
| R13 | C18 | C13 | coref-ident | CNI-1493,CNI-1493 |
| R14 | C20 | C19 | coref-ident | which,the molecular target |
| R15 | C21 | C18 | coref-ident | CNI-1493,CNI-1493 |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-8 | other_organic_compound | denotes | CNI-1493 |
| T2 | 18-59 | protein_family_or_group | denotes | monocyte/macrophage tumor necrosis factor |
| T3 | 78-100 | other_name | denotes | translation efficiency |
| T4 | 102-123 | protein_family_or_group | denotes | Tumor necrosis factor |
| T5 | 125-128 | protein_family_or_group | denotes | TNF |
| T6 | 182-194 | other_name | denotes | septic shock |
| T7 | 232-240 | other_name | denotes | cachexia |
| T8 | 254-281 | other_organic_compound | denotes | multivalent guanylhydrazone |
| T9 | 283-291 | other_organic_compound | denotes | CNI-1493 |
| T10 | 322-343 | other_name | denotes | macrophage activation |
| T11 | 366-369 | protein_family_or_group | denotes | TNF |
| T12 | 919-927 | other_organic_compound | denotes | CNI-1493 |
| T13 | 948-951 | protein_family_or_group | denotes | TNF |
| T14 | 1012-1015 | protein_family_or_group | denotes | TNF |
| T15 | 1016-1038 | other_name | denotes | translation efficiency |
| T16 | 1040-1048 | other_organic_compound | denotes | CNI-1493 |
| T17 | 1069-1087 | lipid | denotes | lipopolysaccharide |
| T18 | 1133-1136 | protein_family_or_group | denotes | TNF |
| T19 | 1167-1192 | protein_molecule | denotes | nuclear factor NF-kappa B |
| T20 | 1200-1207 | cell_component | denotes | nucleus |
| T21 | 1211-1222 | cell_type | denotes | macrophages |
| T22 | 1246-1249 | lipid | denotes | LPS |
| T23 | 1279-1287 | other_organic_compound | denotes | CNI-1493 |
| T24 | 1318-1328 | protein_complex | denotes | NF-kappa B |
| T25 | 1368-1371 | protein_family_or_group | denotes | TNF |
| T26 | 1399-1419 | protein_molecule | denotes | 26-kDa membrane form |
| T27 | 1423-1426 | protein_family_or_group | denotes | TNF |
| T28 | 1454-1462 | other_organic_compound | denotes | CNI-1493 |
| T29 | 1489-1514 | other_name | denotes | translational suppression |
| T30 | 1518-1521 | protein_family_or_group | denotes | TNF |
| T31 | 1552-1586 | protein_molecule | denotes | chloram-phenicol acetyltransferase |
| T32 | 1631-1634 | protein_family_or_group | denotes | TNF |
| T33 | 1661-1664 | protein_family_or_group | denotes | TNF |
| T34 | 1738-1741 | protein_family_or_group | denotes | TNF |
| T35 | 1779-1804 | other_name | denotes | translational suppression |
| T36 | 1808-1816 | other_organic_compound | denotes | CNI-1493 |
| T37 | 1871-1879 | other_organic_compound | denotes | CNI-1493 |
| T38 | 1889-1892 | protein_family_or_group | denotes | TNF |
| T39 | 1951-1972 | other_name | denotes | macrophage activation |
| T40 | 1977-2003 | other_name | denotes | mechanisms of inflammation |